Navigation Links
Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
Date:1/24/2012

593 4202 (mobile)

eric.althoff@novartis.comAnna Frable Novartis Pharmaceuticals Corporation

+1 862 778 5388 (direct)

+1 732 673 5262 (mobile)

anna.frable@novartis.com

 

Julie MasowNovartis Corporate Communications

+1  212 830 2465 (direct)

+1  862 579 8456 (mobile)

julie.masow@novartis.come-mail: media.relations@novartis.comFor Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.Novartis Investor Relations Central phone:+41 61 324 7944

 

 Susanne Schaffert

+41 61 324 3769North America: Pierre-Michel Bringer

+41 61 324 1065

Richard Jarvis

+1 212 830 2433Thomas Hungerbuehler

+41 61 324 8425

Jill Pozarek

+1 212 830 2445Isabella Zinck

+41 61 324 7188

Edwin Valeriano

+1 212 830 2456 

 

 

 e-mail: investor.relations@novartis.com

e-mail: investor.relations@novartis.com 

  

 

 

 

 

 

 

 


'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. inVentiv Health Selected to Provide Sales Operations Support for Santarus
2. Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
3. Generex Augments Cash Position With Sales of Non-Essential Assets
4. Global Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
5. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
6. Simulated Environment Concepts Research Report to be Released - Domestic Sales Force Established
7. First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
8. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
9. WNDM Secures Additional International Sales; $150 K in New Orders for 2011
10. China-Biotics Receives First U.S. Sales Order
11. SeraCare Life Sciences Appoints Sean OConnor as Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 According ... “Consolidation continues to reshape the look and feel of ... Consumer demand for higher-quality ingredients will push for more ... American market have experienced strong market growth in the ... attributes in their food and cosmetics to fit a ...
(Date:8/26/2014)... 26, 2014  NeuroSigma, Inc., a Los ... bioelectronic technologies, today announced that it has filed a ... and Exchange Commission relating to a proposed initial public ... to be offered and the price range for the ... Jefferies LLC will act as the book-running manager for ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... Greater Baltimore,Committee is seeking nominations for the Third ... on Tuesday, March 18, 2008. Those,interested in nominating ... http://www.gbc.org ., The four award categories are: ... and President,s Award. Nominators will,be asked to submit ...
... Jan. 14 VIRxSYS Corporation, a,privately held company ... Lentigen Corporation, a privately-owned biotechnology company,focused on the ... they have agreed to settle the pending litigation ... claims and counterclaims,asserted in the lawsuit, which has ...
... Company Accelerating Efforts to Commercialize Bio-Based Technologies to ... ... DuPont (NYSE: DD ),has named Nicholas C. Fanandakis group ... Fanandakis will lead the,company,s accelerated efforts to commercialize a range ...
Cached Biology Technology:VIRxSYS and Lentigen Announce Litigation Settlement 2DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences 2
(Date:8/27/2014)... beasts. But every creature is a baby once. , ... of 24 very young dinosaurs and one older individual ... a caretaker, according to a new study by University ... Peter Dodson led the work, collaborating with researchers from ... is held. Hedrick is a doctoral student in the ...
(Date:8/27/2014)... rare, but deadly disease that exists as five strains, ... most lethal strains is the Sudan ebolavirus (SUDV). Although ... caused widespread illness, even as recently as 2012. In ... Chemical Biology , researchers now report a possible therapy ... , John Dye, Sachdev Sidhu, Jonathan Lai and colleagues ...
(Date:8/27/2014)... the long-standing belief that a deficiency in serotonin ... central role in depression. In the journal ACS ... ability to make serotonin in their brains (and thus ... show depression-like symptoms. , Donald Kuhn and colleagues ... Wayne State University School of Medicine note that depression ...
Breaking Biology News(10 mins):Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2New study throws into question long-held belief about depression 2
... a gene for a specific protein face a 20-fold greater ... in mBio , the online open-access journal of the ... is the most common cause of fungal meningitis among HIV-infected ... HIV who has a very low level of CD4+ T ...
... at the Medical College of Wisconsin (MCW) have developed ... identify genetic mutations responsible for cancers.The tool, called DrGaP, ... the American Journal of Human Genetics . ... National Cancer Institute, and a former visiting scholar at ...
... FASEB MARC (Maximizing Access to Research Careers) Program ... Writing Seminar and Practical Exercises Workshop at the Marine ... 2012. Awards are given to graduate students, postdocs and ... have never written a successful grant application. This year ...
Cached Biology News:Gene makes some HIV-infected patients more at risk for fungal disease 2Gene makes some HIV-infected patients more at risk for fungal disease 3
Request Info...
... Nuclease catalyzes the degradation of single-stranded DNA ... products. While the nuclease prefers ssDNA over ... the enzyme degrades double-stranded DNA from both ... used for transcript mapping studies (3,4), for ...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
...
Biology Products: